AP NEWS

Global Anti-Fungal Drugs Market Growth, Trends and Forecasts 2018-2023 - ResearchAndMarkets.com

May 16, 2018

DUBLIN--(BUSINESS WIRE)--May 16, 2018--The “Global Anti-Fungal Drugs Market - Segmented by Drug type, Therapeutic Indication and Geography - Growth, Trends and Forecasts (2018 - 2023)” report has been added to ResearchAndMarkets.com’s offering.

The global anti-fungal drugs market is expected to register a CAGR of 3.7% during the forecast period, 2018 to 2023.

With rising popularity of over-the-counter (OTC) drugs, many patients prefer them to obtaining a prescription from a healthcare professional. Numerous common and harmless fungal infections are left untreated by patients, owing to medical costs and logistical constraints. These have directly contributed to the rise in the usage of OTC drugs, as these infections can be treated by OTC drugs, owing to their ease of availability.

Increasing awareness about myriad fungal infections and increasing government and corporate funding are some other drivers of the market.

North America dominates the market due to increasing awareness of fungal infections with the growing incidence of antifungal infections and increasing government and corporate funding in the industry.

Companies Mentioned

Abbott Laboratories Pfizer Glaxosmithkline Bayer Healthcare Novartis Sanofi-Aventis Merck & Co. Kramer Laboratories Enzon Pharmaceuticals Gilead

Key Topics Covered

1. Introduction

2. Research Methodology

3. Executive Summary

4. Key Inferences

5. Market Overview

6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

7. Market Segmentation

8. Competitive Landscape

9. Key Players

10. Future of the Market

For more information about this report visit https://www.researchandmarkets.com/research/lqgw3k/global?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180516005593/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Infectious Diseases Drugs

KEYWORD:

INDUSTRY KEYWORD: HEALTH INFECTIOUS DISEASES PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 05/16/2018 06:31 AM/DISC: 05/16/2018 06:31 AM

http://www.businesswire.com/news/home/20180516005593/en

AP RADIO
Update hourly